Last reviewed · How we verify

AI assisted insulin system — Competitive Intelligence Brief

AI assisted insulin system (AI assisted insulin system) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Diabetes.

marketed Diabetes Small molecule Live · refreshed every 30 min

Target snapshot

AI assisted insulin system (AI assisted insulin system) — Shanghai Zhongshan Hospital. An artificial intelligence-assisted system that optimizes insulin dosing and delivery by analyzing real-time glucose data and patient factors to improve glycemic control.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
AI assisted insulin system TARGET AI assisted insulin system Shanghai Zhongshan Hospital marketed

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). AI assisted insulin system — Competitive Intelligence Brief. https://druglandscape.com/ci/ai-assisted-insulin-system. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: